AINDEX
Markets

Cronos Group Inc. (CRON)

CRONNASDAQ-GM Medicinal Chemicals and Botanical Products

$3.37

-0.0578 (-1.69%) today

Closed, Nov 13, 4:00 PM ET

-1.69% 1D
Market cap
$1.24bn
P/E
42.1
EPS, last 4 quarters
$0.0800
Dividend yield
–
Day range
–
52-week range
$2.28 to $3.91
Average volume
–
Previous close
$3.42

Analysts

1 covering

Buy1 buy, 0 hold, 0 sell

Targets a year out average $4.73, +40.5% from here

$4.55now $3.37$4.90

Earnings

next estimate $0.0400

Next report

Dec 2025

-100.0%

Mar 2026

0.0%

Jun 2026

+200.0%

Sep 2026

+33.3%

estimate reported, and the surprise

Financials

QuarterDec 2025Mar 2026Jun 2026Sep 2026
Revenue$58.38m$58.97m$70.60m$83.90m
Gross profit$16.19m$19.15m$28.45m$32.28m
Operating income-$7.50m-$1.83m$7.40m$9.03m
Net income-$1.82m$13.75m$32.09m$13.80m

Last four quarters: revenue $271.85m, margin 21.3%, free cash flow $65.38m

News

8 latest

The company

Cronos is a global cannabis company focused on scaling leading consumer goods products through R&D and innovation. With a passion to responsibly elevate the consumer experience, Cronos is building an iconic brand portfolio.

Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Exchange
NASDAQ-GM
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.

Cronos Group Inc. (CRON) price, chart and news · AINDEX